← All peptides
Hormones & TRT
Clinical

Testosterone Enanthate

Also known as: Test E, Xyosted

A long-acting injectable testosterone ester used for testosterone replacement therapy. Clinically near-interchangeable with cypionate. Prescription medication.

Last updated

Mechanism of Action

An esterified testosterone that is slowly released after injection and cleaved to free testosterone, which activates the androgen receptor. Pharmacokinetics are very similar to cypionate; the enanthate ester gives a comparable multi-day half-life supporting weekly or twice-weekly dosing.

Half-life
~7 days (enanthate ester)
Administration Routes
Intramuscular, Subcutaneous
Research Status
Clinical

Reported Benefits

  • Restores serum testosterone in diagnosed hypogonadism
  • Supports libido, mood, energy, lean mass, and bone density
  • Stable levels with weekly or split dosing

Potential Side Effects

  • Erythrocytosis (elevated hematocrit)
  • Estrogenic effects via aromatization
  • Testicular atrophy and reduced fertility
  • Acne, oily skin

Common Dosing

Reported TRT dosing is typically 100-200 mg per week, frequently split, titrated to labs and symptoms under physician supervision.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Prostate or breast cancer
  • Untreated erythrocytosis
  • Pregnancy
  • Uncontrolled cardiovascular disease — medical supervision required
  • The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men

    1996

    View
  • Testosterone dose-response relationships in healthy young men

    2001

    View
  • Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study

    2015

    View
  • Post-market safety and efficacy profile of subcutaneous testosterone enanthate-autoinjector: a cohort analysis

    2022

    View

Very little clinically. The esters differ slightly in half-life; both support weekly or twice-weekly TRT dosing. Choice is usually availability or prescriber preference.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.